R&G PharmaStudies Co. Ltd. A Free Cash Flow Generation Index
R&G PharmaStudies Co. Ltd. A free cash flow generation index. R&G PharmaStudies Co. Ltd. A (301333) has a Free Cash Flow Generation Index of 0.87x as of June 2022. Free cash flow of CN¥35.74 Million represents 1% of operating cash flow (CN¥40.98 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of R&G PharmaStudies Co. Ltd. A (2019–2025)
Free cash flow generation index of R&G PharmaStudies Co. Ltd. A from 2019 to 2025. Historical FCF Generation Index trend for R&G PharmaStudies Co. Ltd. A across 7 annual periods. See 301333 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
R&G PharmaStudies Co. Ltd. A Free Cash Flow Generation Index by Year (2019–2025)
R&G PharmaStudies Co. Ltd. A free cash flow generation index by year from 2019 to 2025. Year-by-year Free Cash Flow Generation Index for R&G PharmaStudies Co. Ltd. A. For the full cash flow conversion analysis, see 301333 operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.83x | CN¥94.93 Million | CN¥114.20 Million | CN¥19.28 Million | ▼ -4.6% |
| 2024 | 0.87x | CN¥134.78 Million | CN¥154.76 Million | CN¥19.98 Million | ▼ -2.9% |
| 2023 | 0.90x | CN¥172.68 Million | CN¥192.56 Million | CN¥19.88 Million | ▲ +6.7% |
| 2022 | 0.84x | CN¥109.64 Million | CN¥130.47 Million | CN¥20.83 Million | ▲ +26.2% |
| 2021 | 0.67x | CN¥76.29 Million | CN¥114.57 Million | CN¥38.28 Million | ▲ +57.7% |
| 2020 | 0.42x | CN¥18.62 Million | CN¥44.10 Million | CN¥25.48 Million | ▼ -43.6% |
| 2019 | 0.75x | CN¥77.47 Million | CN¥103.48 Million | CN¥26.00 Million | — |